Roberts Jordan A, Waters Lindsay, Ro Jae Y, Zhai Qihui Jim
Department of Pathology, Houston Methodist Hospital, Weill College of Medicine, Cornell University Houston, TX.
Department of Pathology, Houston Methodist Hospital, Weill College of Medicine, Cornell University Houston, TX ; Department of Lab Medicine and Pathology, Mayo Clinic Jacksonville, FL.
Int J Clin Exp Pathol. 2014 Jan 15;7(2):792-6. eCollection 2014.
An accurate distinction between deep muscularis propria invasion versus subserosal invasion by colonic adenocarcinoma is essential for the accurate staging of cancer and subsequent optimal patient management. However, problems may arise in pathologic staging when extensive desmoplasia blurs the junction between deep muscularis propria and subserosal fibroadipose tissue. To address this issue, forty-three (43) cases of colonic adenocarcinoma resections from 2007-2009 at The Methodist Hospital in Houston, TX were reviewed. These cases were selected to address possible challenges in differentiating deep muscularis propria invasion from superficial subserosal invasion based on H&E staining alone. Immunohistochemical staining using smooth muscle actin (SMA), smoothelin, and caldesmon were performed on 51 cases: 8 cases of pT1 tumors (used mainly as control); 12 pT2 tumors; and 31 pT3 tumors. All 51 (100%) had diffuse, strong (3+) immunoreactivity for caldesmon and smoothelin in the muscularis propria with a granular cytoplasmic staining pattern. However, the desmoplastic areas of these tumors, composed of spindled fibroblasts and myofibroblasts, showed negative immunostaining for caldesmon and smoothelin (0/35). SMA strongly stained the muscularis propria and weakly (1+) or moderately (2+) stained the spindled fibroblasts in the desmoplastic areas (the latter presumably because of myofibroblastic differentiation). Compared to SMA, caldesmon and smoothelin are more specific stains that allow better delineation of the muscularis propria from the desmoplastic stromal reaction which provides a critical aide for proper staging of colonic adenocarcinoma and subsequent patient care.
准确区分结肠腺癌的固有肌层深层浸润与浆膜下浸润对于癌症的准确分期及后续患者的最佳管理至关重要。然而,当广泛的促纤维增生使固有肌层深层与浆膜下纤维脂肪组织之间的界限模糊时,病理分期可能会出现问题。为解决这一问题,回顾了2007年至2009年在德克萨斯州休斯顿卫理公会医院进行的43例结肠腺癌切除术病例。选择这些病例是为了解决仅基于苏木精-伊红(H&E)染色区分固有肌层深层浸润与浅表浆膜下浸润可能面临的挑战。对51例病例进行了平滑肌肌动蛋白(SMA)、平滑肌肌动蛋白相关蛋白(smoothelin)和钙调蛋白(caldesmon)的免疫组织化学染色:8例pT1肿瘤(主要用作对照);12例pT2肿瘤;31例pT3肿瘤。所有51例(100%)固有肌层中钙调蛋白和平滑肌肌动蛋白相关蛋白均呈弥漫性、强(3+)免疫反应,呈颗粒状细胞质染色模式。然而,这些肿瘤的促纤维增生区域由梭形成纤维细胞和成肌纤维细胞组成,钙调蛋白和平滑肌肌动蛋白相关蛋白免疫染色呈阴性(0/35)。SMA强烈染色固有肌层,而在促纤维增生区域中梭形成纤维细胞呈弱(1+)或中度(2+)染色(后者可能是由于成肌纤维细胞分化)。与SMA相比,钙调蛋白和平滑肌肌动蛋白相关蛋白是更具特异性的染色剂,能更好地将固有肌层与促纤维增生性基质反应区分开来,这为结肠腺癌的正确分期及后续患者护理提供了关键帮助。